168 related articles for article (PubMed ID: 32626448)
1. Moving towards a holistic approach for human health risk assessment - Is the current approach fit for purpose?
Bennekou SH
EFSA J; 2019 Jul; 17(Suppl 1):e170711. PubMed ID: 32626448
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
5. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
[TBL] [Abstract][Full Text] [Related]
6. New Toxicology Tools and the Emerging Paradigm Shift in Environmental Health Decision-Making.
Ginsberg GL; Pullen Fedinick K; Solomon GM; Elliott KC; Vandenberg JJ; Barone S; Bucher JR
Environ Health Perspect; 2019 Dec; 127(12):125002. PubMed ID: 31834829
[TBL] [Abstract][Full Text] [Related]
7. Integrated testing and intelligent assessment-new challenges under REACH.
Ahlers J; Stock F; Werschkun B
Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
[TBL] [Abstract][Full Text] [Related]
8. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
9. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
10. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
[TBL] [Abstract][Full Text] [Related]
11. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
12. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
13. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
[TBL] [Abstract][Full Text] [Related]
14. Probabilistic risk assessment - the keystone for the future of toxicology.
Maertens A; Golden E; Luechtefeld TH; Hoffmann S; Tsaioun K; Hartung T
ALTEX; 2022; 39(1):3-29. PubMed ID: 35034131
[TBL] [Abstract][Full Text] [Related]
15. Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.
Coady KK; Biever RC; Denslow ND; Gross M; Guiney PD; Holbech H; Karouna-Renier NK; Katsiadaki I; Krueger H; Levine SL; Maack G; Williams M; Wolf JC; Ankley GT
Integr Environ Assess Manag; 2017 Mar; 13(2):302-316. PubMed ID: 27791330
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
[TBL] [Abstract][Full Text] [Related]
17. Endocrine Disruptors in a New Era of Predictive Toxicology and Dealing With the
Svingen T
Front Toxicol; 2022; 4():900479. PubMed ID: 35573277
[TBL] [Abstract][Full Text] [Related]
18. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.
Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG
Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220
[TBL] [Abstract][Full Text] [Related]
19. Contribution of new technologies to characterization and prediction of adverse effects.
Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
[TBL] [Abstract][Full Text] [Related]
20. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
Paparella M; Bennekou SH; Bal-Price A
Reprod Toxicol; 2020 Sep; 96():327-336. PubMed ID: 32781019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
